What’s New – Guidance for prioritization of laboratory systems and services
ASLM is developing a minimum package of laboratory care framework that provides a structured and evidence-based approach to prioritize and sustain critical diagnostic services in t
Estimating the demand for tuberculosis diagnostics closer to the point of care
Despite being declared a global emergency in 1993, tuberculosis (TB) still claims the lives of over 1 million people each year. Additionally, approximately 2 million people who hav
Lab Lessons from the Frontlines: April–June 2025 in Review
Between April and June 2025, the Laboratory Systems Strengthening Community of Practice (LabCoP), with support from the Gates Foundation and partner organizations, convened ten imp
June 2025 LabCoP Extended ECHO Session: Flying blind: the urgent need for rapid detection of bedaquiline-resistant TB
The emergence of drug-resistant TB remains a global health threat, with only one-third of individuals estimated to have multi-drug (MDR) or rifampicin-resistant (RR) TB diagnosed a
June 2025 Science Webinar: From Lab to Market Place: ABCs of Diagnostic Product Development
The ASLM Science and Innovation Webinar Series aims to provide a platform for the latest scientific advancements, knowledge sharing, and skill enhancement for laboratory medicine p
Dissemination of the Report on the Status of Laboratory Professional Associations in Africa
Across Africa, medical laboratory associations are essential for advocacy, professional growth, and quality diagnostics, yet their capacities and resources vary widely. The Federat
June 2025 LabCoP Extended ECHO session: Making Genomics Work for TB: Practical and Cost-Effective Use of tNGS in TB Programs
The emergence of drug-resistant TB remains a global health threat, with only one-third of individuals estimated to have multi-drug (MDR) or rifampicin-resistant (RR) TB diagnosed a
May 2025 LabCoP Extended Echo Session. Closing the gap in drug-resistant TB diagnosis: the critical role of sequencing
The emergence of drug-resistant TB remains a global health threat, with only one-third of individuals estimated to have multi-drug (MDR) or rifampicin-resistant (RR) TB diagnosed a
May 2025 LabCoP Extended ECHO Session: Experiences, challenges and lessons learnt in improving the public health laboratories surveillance capabilities for priority diseases The experiences of Burkina Faso, and São Tomé and Príncipe
In this ECHO session,São Tomé and Príncipe, and Burkina Faso shares their experiences, challenges, lessons learnt and priority areas in improving detection, surveillance and res
ASLM Annual Report 2023 – 2025
As we reflect on the past two years, I am filled with immense pride and appreciation for the remarkable strides achieved at the African Society for Laboratory Medicine (ASLM). Our